NCT04929028 2026-03-18Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerNational Cancer Institute (NCI)Phase 2 Recruiting40 enrolled
NCT06780787 2025-06-26FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before SurgeryCity of Hope Medical CenterPhase 2 Recruiting26 enrolled